MiniMed Group, Inc. (MMED) News
Track canonical SquawkNews coverage tagged to MMED, MiniMed Group, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 32 indexed stories across 12 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
MiniMed (MMED) Appoints Sheila Denton as General Counsel
MiniMed appointed Sheila Denton as General Counsel & Corporate Secretary, effective immediately, succeeding Courtney Nelson Wills.Material DetailsContext by AI AnalystThis is an early governance move as MiniMed scales as
NEWS | Sep 28, 2026, 01:03 PM UTC
L
MiniMed appoints Sheila Denton as General Counsel & Corporate Secretary
NORTHRIDGE, Calif., Sept. 28, 2026 // -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that Sheila Denton has been named General Counsel & Corporate Secretary."Sheila brings deep board e
NEWS | Sep 28, 2026, 01:03 PM UTC
L
MiniMed Group Initiated at Buy by Truist Securities
Ratings actions from Benzinga
NEWS | Sep 24, 2026, 03:27 PM UTC
M
Medtronic starts exchange offer to split off at least 80.1% of Minimed
Medtronic: Exchange Offer Will Permit Hldrs to Exchange Their Ordinary Shrs for Shrs of MiniMed Common Stk at 7% Discount >MDT
MNA | Sep 14, 2026, 11:38 AM UTC
L
MMED net sales rise 16.6% to $843M; EBITDA improves
Net sales rose 16.6% to $843 million, driven by strong pump and CGM growth. Gross margin declined on a higher mix of lower-margin CGM products, while the net loss improved and Adjusted EBITDA more than doubled.
EARNINGS | Sep 08, 2026, 08:30 PM UTC
M
MMED growth lifts as new launches target Type 2 expansion
MMED says U.S. growth accelerated in Q1 on new product launches, including Fit patch pump and a Vivera algorithm aimed at expanding the Type 2 market. Manufacturing and pharmacy strategies support upcoming launches; inte
EQUITY | Sep 08, 2026, 08:23 PM UTC
L
MMED: New product launches and innovation drive U.S. and international growth, with strong outlook
U.S. growth accelerated in Q1, driven by new product launches and sustained by a robust innovation pipeline. The Fit patch pump and Vivera algorithm are set to expand the market, especially among type 2 patients, while i
EQUITY | Sep 08, 2026, 07:56 PM UTC
L
MiniMed Q1 sales rose; UBS lifts price target to $28
MiniMed Group reported Q1 FY2027 net sales of $843M, up 16.6% (15.8% organic). UBS raised its price target to $28 and reiterated a Buy, citing U.S. and international organic growth.
EARNINGS | Sep 07, 2026, 11:22 AM UTC
L
MiniMed Group kept at Overweight by Morgan Stanley
Morgan Stanley maintained its Overweight rating on MiniMed Group.
EQUITY | Sep 03, 2026, 02:32 PM UTC
L
Evercore ISI raises MiniMed Group price target to $27
Evercore ISI Group raised its price target on MiniMed Group to $27.00 per share, from $20.00.
EQUITY | Sep 02, 2026, 03:20 PM UTC
L
Wells Fargo raises MiniMed Group price target to $26
Wells Fargo maintained MiniMed Group at Overweight and raised its price target to $26.00 per share from $22.00.
EQUITY | Sep 02, 2026, 02:50 PM UTC
L
UBS raises MiniMed Group price target to $28 from $25
UBS maintained a Buy rating on MiniMed Group and raised its price target to $28.00 per share from $25.00, according to Benzinga via TradingView News.
EQUITY | Sep 02, 2026, 01:53 PM UTC
L
Mizuho maintains Outperform on MiniMed Group; price target raised
Mizuho maintained its Outperform rating on MiniMed Group and raised its price target to $26.00 per share from $21.00.
EQUITY | Sep 02, 2026, 01:20 PM UTC
L
B of A Securities maintains Buy on MiniMed Group
Benzinga’s ratings coverage says B of A Securities maintained a Buy rating for MiniMed Group.
EQUITY | Sep 02, 2026, 11:56 AM UTC
M
PFE, MMED, DE hit new 52-week highs amid rotation into defensives
Pfizer (PFE), MiniMed (MMED) and Deere (DE) reached new 52-week highs Tuesday. MMED jumped over 10%, while DE gained 3% and PFE rose 0.3% as investors rotated toward healthcare, diabetes tech and AI-driven industrial gro
EQUITY | Sep 02, 2026, 02:52 AM UTC
L
MiniMed Group Inc reports results for the quarter ended July 31 - Earnings Summary
FORECAST CHANGESRECOMMENDATIONSThis summary was machine generated from LSEG data September 1 at 09:06 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, conta
EARNINGS | Sep 01, 2026, 09:06 PM UTC
L
MiniMed jumps after first-quarter revenue beat; Tidewater lifts on BTIG view
MiniMed (MMED) rose more than 10% after a first-quarter revenue beat, reaching an all-time high of $22. Tidewater (TDW) gained 6% after BTIG forecast an additional $300 million in earnings over the next couple of years.
EARNINGS | Sep 01, 2026, 06:06 PM UTC
L
BTIG raises MiniMed Group price target to $28 from $25
BTIG raised its MiniMed Group price target to $28.00 per share from $25.00, according to Benzinga ratings actions cited by TradingView News.
EQUITY | Sep 01, 2026, 05:22 PM UTC
L
MMED Q1 organic revenue rises 16%; fiscal 2027 guidance raised
MMED reported Q1 delivered 16% organic revenue growth, driven by strong U.S. and international performance plus new product launches and expanding recurring revenue.
EARNINGS | Sep 01, 2026, 03:33 PM UTC
M
MiniMed shares rise after fiscal first-quarter sales jump
MiniMed Group shares climbed 8.1% to $21.91 after reporting higher sales in its fiscal first quarter, supported by continued international growth and accelerating U.S. growth.
EQUITY | Sep 01, 2026, 03:04 PM UTC
L
Minimed Group raises 2027 organic revenue outlook after Q1 growth
Minimed Group said first-quarter organic revenue grew 16% to $843 million and lifted fiscal 2027 organic revenue growth guidance to 10.5%, while reaffirming a 16% adjusted EBITDA margin target.
EARNINGS | Sep 01, 2026, 01:56 PM UTC
L
MMED highlights diabetes technology growth and expanding global reach
MMED says a comprehensive diabetes technology platform is driving strong growth, citing a refreshed product portfolio, best-in-class clinical outcomes, accelerating revenue, margin expansion, and a solid balance sheet.
EQUITY | Sep 01, 2026, 01:14 PM UTC
L
MMED reports 843.0M revenue; EPS -0.775 misses
MMED posted revenue of 843.0M, above estimates by 14.7M and up 16.60% YoY. EPS was -0.775, missing estimates by -0.09 with 868.75% YoY growth.
EARNINGS | Sep 01, 2026, 10:56 AM UTC
L
MMED posts 17% Q1 FY27 net sales growth, lifts guidance
MMED reported 17% Q1 FY27 net sales growth and raised full-year organic revenue growth guidance to 10.5%. It also cited an adjusted EBITDA margin of 16%.
EARNINGS | Sep 01, 2026, 10:53 AM UTC
L
MiniMed Group reports 1Q EPS of 0c
MiniMed Group posted 1Q EPS of 0c.
EARNINGS | Sep 01, 2026, 10:47 AM UTC
L
MiniMed Group 1Q sales $843M; MMED
MiniMed Group reported 1Q sales of $843M for MMED.
EQUITY | Sep 01, 2026, 10:47 AM UTC
L
MMED - MiniMed Delivers Strong Start to Fiscal Year 2027 with U.S. Growth Acceleration
MMED - MiniMed Delivers Strong Start to Fiscal Year 2027 with U.S. Growth Acceleration
EQUITY | Sep 01, 2026, 10:46 AM UTC
L
MiniMed Delivers Strong Start to Fiscal Year 2027 with U.S. Growth Acceleration
NORTHRIDGE, Calif., Sept. 1, 2026 // -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today reported financial results for its first quarter (Q1) of fiscal year 2027 (FY27), ended July 31, 2026."MiniMed
EQUITY | Sep 01, 2026, 10:45 AM UTC
L
MiniMed Group Inc expected to post earnings of 9 cents a share - Earnings Preview
MiniMed Group Inc expected to post earnings of 9 cents a share - Earnings Preview
EARNINGS | Aug 28, 2026, 12:32 PM UTC
L
MiniMed (MMED) schedules participation in upcoming investor conferences
MiniMed (MMED) says it will participate in upcoming investor conferences, without providing any earnings, financial figures, or specific guidance in the release.
EQUITY | Aug 25, 2026, 01:03 PM UTC
L
MiniMed’s smallest app-controlled insulin pump starts shipping
MiniMed’s smallest app-controlled insulin pump is now shipping with the world’s smallest sensor, according to TradeXchange Newsdesk.
EQUITY | Aug 17, 2026, 01:04 PM UTC
H
Analysts Initiate Buys
Analysts initiate buy ratings
EQUITY | Jul 29, 2026, 11:15 AM UTC